Stay updated on Long-term Esketamine Study in Depression: Clinical Trial

Sign up to get notified when there's something new on the Long-term Esketamine Study in Depression: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-term Esketamine Study in Depression: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a modification in the dosage of intranasal esketamine for participants with treatment-resistant depression in a long-term safety and efficacy study.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:52.000Z thumbnail image
  6. Check
    20 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying the requirements for direct-entry and transferred-entry participants in the study. Previously, no information was provided under the Participation Criteria Collaborators section.
    Difference
    26%
    Check dated 2024-05-22T21:18:06.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:43:13.000Z thumbnail image

Stay in the know with updates to Long-term Esketamine Study in Depression: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-term Esketamine Study in Depression: Clinical Trial page.